Related Experiment Video
Updated: May 1, 2026

Author Spotlight: Alleviating Nausea and Vomiting in Pregnancy with Safe and Effective Auricular Acupuncture
Published on: August 4, 2023
Italian multidisciplinary delphi consensus on home management of nausea and vomiting in children with acute
Ruggiero Francavilla1, Fernanda Cristofori1, Gian Luigi Marseglia2,3
1Interdisciplinary Department of Medicine, Pediatric Section, Children's Hospital 'Giovanni XXIII', University of Bari Aldo Moro, Bari, Italy.
Insights
Vomiting in pediatric acute gastroenteritis (AGE) is common. Expert consensus supports cautious antiemetic use, like metoclopramide, for home management in select cases to aid rehydration and reduce distress.
Area of Science:
- Pediatric Gastroenterology
- Clinical Pharmacology
- Evidence-Based Medicine
Background:
- Vomiting in pediatric acute gastroenteritis (AGE) causes significant distress and hinders oral rehydration.
- Limited guidance exists for home management and antiemetic use in children, compounded by regulatory issues.
Purpose of the Study:
- To establish expert consensus on managing vomiting in pediatric AGE.
- To provide recommendations for the safe and effective use of antiemetics, particularly metoclopramide, in home settings.
Main Methods:
- A modified Delphi consensus process was employed.
- A national multidisciplinary panel of 70 Italian pediatricians participated in three phases: literature review, anonymous online rating, and refinement.
- Twenty-one statements on clinical aspects and antiemetic use were rated using a five-point Likert scale, with consensus defined as ≥80% agreement.
Main Results:
- All 21 statements achieved consensus (83%-100% agreement).
- High agreement was reached on the clinical impact of vomiting in AGE, its mechanisms, and metoclopramide safety (dosing, age considerations, counseling).
- The panel agreed that cautious antiemetic use, especially metoclopramide, can support home management for persistent vomiting if safety protocols are followed.
Conclusions:
- This Delphi consensus offers practical, expert-backed recommendations for managing nausea and vomiting in pediatric AGE at home.
- Oral rehydration solutions (ORS) are primary treatment; metoclopramide may be considered for symptom resolution and facilitating rehydration in select cases.
- Strict risk-benefit assessment and adherence to clinical safeguards are crucial when prescribing antiemetics like metoclopramide.
Introduction:
Vomiting in pediatric acute gastroenteritis (AGE) is a major driver of distress, caregiver anxiety, and failure of oral rehydration, while guidance for home management and pediatric antiemetic use is limited and influenced by regulatory restrictions.
Methods:
We conducted a modified Delphi consensus in three phases (statement development after literature review, anonymous online rating, and final refinement) involving a national multidisciplinary panel of 70 Italian pediatricians.
Results:
Twenty-one statements addressing clinical aspects of vomiting in AGE and the pharmacology, safety, and use of commonly prescribed antiemetics (with emphasis on metoclopramide) were rated on a five-point Likert scale; consensus was predefined as ≥80% ratings of 4-5. All 21 statements met the consensus threshold (agreement 83%-100%; mean scores 4.2-4.9). The highest agreement concerned the clinical burden of vomiting in AGE, key mechanistic pathways, and practical safety considerations for metoclopramide (including dosing limits, age-related caution, and caregiver counseling). The panel agreed that, in selected children with persistent vomiting preventing oral rehydration, cautious antiemetic use, particularly metoclopramide, may support home management when safety precautions are followed, off-label requirements are respected, and parents are adequately counseled.
Discussion:
This Delphi consensus provides pragmatic, expert-endorsed recommendations for home management of nausea and vomiting in pediatric AGE. Oral rehydration solutions (ORS) remain the cornerstone of care; metoclopramide may be considered in carefully selected cases to quickly resolve symptoms, facilitate rehydration and reduce dehydration risk, provided that clinicians adopt strict risk-benefit assessment and good clinical practice safeguards.
More Related Videos
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Pathophysiology of Vomiting
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...

